Richard L. Raymond

Array ( [id] => 4008348 [patent_doc_number] => 05888980 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-30 [patent_title] => 'Compositions for enhancing immune function' [patent_app_type] => 1 [patent_app_number] => 8/475173 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6094 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/888/05888980.pdf [firstpage_image] =>[orig_patent_app_number] => 475173 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3992986 [patent_doc_number] => 05891906 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-04-06 [patent_title] => 'Polyacetate-derived phorboids having anti-inflammatory and other uses' [patent_app_type] => 1 [patent_app_number] => 8/472436 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47171 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/891/05891906.pdf [firstpage_image] =>[orig_patent_app_number] => 472436 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3807855 [patent_doc_number] => 05854229 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-29 [patent_title] => 'Therapeutic methods and delivery systems utilizing sex steroid precursors' [patent_app_type] => 1 [patent_app_number] => 8/477173 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 32 [patent_no_of_words] => 14740 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/854/05854229.pdf [firstpage_image] =>[orig_patent_app_number] => 477173 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3591087 [patent_doc_number] => 05567735 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-10-22 [patent_title] => 'Therapeutic amides' [patent_app_type] => 1 [patent_app_number] => 8/476407 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39073 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 399 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/567/05567735.pdf [firstpage_image] =>[orig_patent_app_number] => 476407 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3967030 [patent_doc_number] => 05886019 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-23 [patent_title] => 'Protein kinase C modulators. F.' [patent_app_type] => 1 [patent_app_number] => 8/475522 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47374 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 180 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/886/05886019.pdf [firstpage_image] =>[orig_patent_app_number] => 475522 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4048062 [patent_doc_number] => 05869478 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-09 [patent_title] => 'Sulfonamido substituted benzopyran derivatives' [patent_app_type] => 1 [patent_app_number] => 8/481007 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15099 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 324 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/869/05869478.pdf [firstpage_image] =>[orig_patent_app_number] => 481007 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3614225 [patent_doc_number] => 05565552 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-10-15 [patent_title] => 'Method of expanded porphyrin-oligonucleotide conjugate synthesis' [patent_app_type] => 1 [patent_app_number] => 8/487722 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4651 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/565/05565552.pdf [firstpage_image] =>[orig_patent_app_number] => 487722 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3692686 [patent_doc_number] => 05595726 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-21 [patent_title] => 'Chromophore probe for detection of nucleic acid' [patent_app_type] => 1 [patent_app_number] => 8/486311 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4599 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/595/05595726.pdf [firstpage_image] =>[orig_patent_app_number] => 486311 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3662332 [patent_doc_number] => 05656662 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-12 [patent_title] => 'Synthesis of optically pure 4-alkenyl- or 4-alkanyl-2-hydroxytetronic acids' [patent_app_type] => 1 [patent_app_number] => 8/485209 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22322 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/656/05656662.pdf [firstpage_image] =>[orig_patent_app_number] => 485209 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3984215 [patent_doc_number] => 05861424 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-19 [patent_title] => 'Composition and method for treating cancer' [patent_app_type] => 1 [patent_app_number] => 8/478582 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 13 [patent_no_of_words] => 15273 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 678 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/861/05861424.pdf [firstpage_image] =>[orig_patent_app_number] => 478582 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3666816 [patent_doc_number] => 05668257 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-16 [patent_title] => 'Phenylboronic acid complexing reagents derived from aminolalicylic acid' [patent_app_type] => 1 [patent_app_number] => 8/482883 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 6653 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/668/05668257.pdf [firstpage_image] =>[orig_patent_app_number] => 482883 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4119612 [patent_doc_number] => 06071970 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-06 [patent_title] => 'Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases' [patent_app_type] => 1 [patent_app_number] => 8/485038 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42411 [patent_no_of_claims] => 185 [patent_no_of_ind_claims] => 63 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/071/06071970.pdf [firstpage_image] =>[orig_patent_app_number] => 485038 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4040030 [patent_doc_number] => 05856571 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-05 [patent_title] => 'Semicarbazide-containing linker compounds for formation of stably-linked conjugates and methods related thereto' [patent_app_type] => 1 [patent_app_number] => 8/486980 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9654 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/856/05856571.pdf [firstpage_image] =>[orig_patent_app_number] => 486980 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4031967 [patent_doc_number] => 05994354 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-30 [patent_title] => 'Cyclic urethanes useful as antiarrhythmic and antifibrillatory agents' [patent_app_type] => 1 [patent_app_number] => 8/479254 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17384 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 245 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/994/05994354.pdf [firstpage_image] =>[orig_patent_app_number] => 479254 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3992427 [patent_doc_number] => 05891870 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-04-06 [patent_title] => 'Protein kinase C modulators Q' [patent_app_type] => 1 [patent_app_number] => 8/472871 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47166 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 161 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/891/05891870.pdf [firstpage_image] =>[orig_patent_app_number] => 472871 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4240412 [patent_doc_number] => 06080784 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-27 [patent_title] => 'Protein kinase C modulators N' [patent_app_type] => 1 [patent_app_number] => 8/480251 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11942 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 749 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/080/06080784.pdf [firstpage_image] =>[orig_patent_app_number] => 480251 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3690748 [patent_doc_number] => 05660813 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-26 [patent_title] => 'Method of screening of angiotens in II type I receptor antagonists' [patent_app_type] => 1 [patent_app_number] => 8/467456 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 8 [patent_no_of_words] => 5708 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/660/05660813.pdf [firstpage_image] =>[orig_patent_app_number] => 467456 [rel_patent_id] =>[rel_patent_doc_number] =>)